The Director General of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof. Mojisola Adeyeye, has alerted the public of the activities of some fraudsters whom she said, hacked into her social media accounts to dupe unsuspected members of the public.
To this end, Adeyeye said she would no longer be using the social media accounts until further notice.
The NAFDAC boss stated this in Abuja, Tuesday, on the sideline of a press conference, she addressed on some contaminated paediatric cough syrups circulating in the Gambia, which she feared could penetrate into Nigeria.
She said, “The attention of NAFDAC has been drawn to the activities of some impostors and fraudulent individuals impersonating the Director General of NAFDAC, Prof Mojisola Christianah Adeyeye via her social media accounts, Facebook and Linkedin.
“These impostors are asking for money in exchange for employment and other favours.
“This is a security breach. NAFDAC and the Director General will never request for gratification to carry out its mandate.
“As a result of this, the social media account of the Director General will no longer be in use until further notice.
“Members of the public are hereby advised to exercise due caution and report any such activity to EFCC (+2348093322644) or Department of State Services (+2349153391309) in Nigeria. For International, call UK Interpol (+44 797 115 3192) or US Federal Bureau of Investigation (+1-800-225-5324).”
Speaking on the contaminated paediatric syrups in circulation in Gambia,she recalled that,”On 5th of October 2022, the World Health Organization (WHO) issued a global alert for over four (4) cough syrups – warning they could be linked to acute kidney injuries and the children’s deaths in July, August, and September in The Gambia.”
She said: “Interviews conducted on bereaved parents in The Gambia by health authorities and law enforcement agencies revealed how their children are not able to pass urine after being given the syrups. As their condition worsened, efforts to save their lives were fruitless which resulted in the death of over 66 children. This is a worrisome development which once again beams a searchlight on the essence of effective regulation and control of medical products.
“As a member of the WHO Programme on International Drug Monitoring and following our active participation in the WHO member state mechanism on substandard and falsified medical products, NAFDAC is leaving no stone unturned in ensuring that these products do not cause harm to our people. As part of our regulatory controls, NAFDAC has issued an alert to the public on Public Alert No. 039/2022 – Alert on Substandard (contaminated) paediatric cough syrups circulating in the Gambia. This alert has been widely circulated on our website and all social media handles and sent to all healthcare providers on our database as well as professional bodies and associations in the medicine supply chain.
“In addition, we have put appropriate measures in place to prevent the entry of these spurious products from the various ports of entry and have activated our internal surveillance mechanisms to mop up these products from the supply chain pipeline if they are ever found.
“These suspected medical products – Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup – were manufactured by an Indian company, Maiden Pharmaceuticals, which had failed to provide guarantees about their safety.
“The National Agency for Food and Drugs Administration and Control (NAFDAC) is using these mediums to further notify healthcare providers and awaken the consciousness of the public on these four substandard products, identified in The Gambia and reported to WHO in September 2022.
The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
“According to the WHO report, laboratory analysis of samples of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.
“Diethylene glycol and ethylene glycol are restricted chemicals which are toxic to humans when consumed and can prove fatal. These chemicals are closely related in chemical structure to propylene glycol which is the right vehicle for use in the manufacture of paediatric syrups.
” Poor quality control might have led to non-detection of these dangerous by products and hence the fatality we have on our hands in the Gambia.
“The notable examples of drug quality problems resulting to serious public consequences and highlighting the significance of NAFDAC include: the disaster of poorly compounded Chloroquine syrup at UNTH Enugu in 1990, Paracetamol syrup disaster at UCH Ibadan and JUTH in 1990, fake meningitis vaccine circulating in Northern Nigeria in 1996, reported cases of contaminated infusions in circulation in 2002, and the “My Pikin” saga in 2008 that was a result of negligence in manufacturing, resulting in poorly formulated Paracetamol syrup. Under my watch as Director-General (NAFDAC), we are working assiduously to ensure this does not happen again in our dear country.
“It is pertinent to note that toxic effects of this contamination in cough syrup include abdominal pain, vomiting, diarrhea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.
“The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products.
According to WHO, the four cold and cough syrups in question have been potentially linked with acute kidney injuries and 66 deaths among children in Gambia.”